Literature DB >> 10671210

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells.

M G Netea1, C H Selzman, B J Kullberg, J M Galama, A Weinberg, A F Stalenhoef, J W Van der Meer, C A Dinarello.   

Abstract

Accumulating evidence suggest that infection with Chlamydia pneumoniae is associated with atherosclerosis, but the mechanisms involved remain unclear. Inflammation is important in the initial phase of atherogenesis, and cytokines are important in the initiation and progression of inflammation. The aim of this study was to assess the capacity of acellular components of C. pneumoniae to stimulate the production of pro-inflammatory cytokines and chemokines. Peripheral blood mononuclear cells were stimulated in vitro with sonicated C. pneumoniae. Significant amounts of TNF-alpha, IL-1, IL-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) were produced. Inhibition of endotoxin using polymyxin B revealed that chlamydial endotoxin plays a minor role in the cytokine induction. Neutralization of TNF by TNF-binding protein and blockade of IL-1 receptors by IL-1 receptor antagonist revealed that TNF, IL-1 and IL-6 production was independent from each other, whereas IL-8 synthesis was strongly dependent on endogenous TNF and IL-1. In contrast, synthesis of MCP-1 and MIP-1alpha was dependent on endogenous TNF, but not IL-1. In conclusion, acellular components of C. pneumoniae are a potent stimulus for cytokine production, and this mechanism may have an important role in the inflammatory aspects of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671210     DOI: 10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Infection and activation of monocytes by Marburg and Ebola viruses.

Authors:  U Ströher; E West; H Bugany; H D Klenk; H J Schnittler; H Feldmann
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients.

Authors:  Pasquale Esposito; Carmine Tinelli; Carmelo Libetta; Elisa Gabanti; Teresa Rampino; Antonio Dal Canton
Journal:  Cell Stress Chaperones       Date:  2010-10-05       Impact factor: 3.667

3.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

4.  Synergistic Costimulatory Effect of Chlamydia pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated Interleukin-1β Secretion in Macrophages.

Authors:  Junji Matsuo; Shinji Nakamura; Seiji Takeda; Kasumi Ishida; Tomohiro Yamazaki; Mitsutaka Yoshida; Hitoshi Chiba; Shu-Ping Hui; Hiroyuki Yamaguchi
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

5.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

Review 6.  Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Authors:  J Thomas Grayston; Robert J Belland; Gerald I Byrne; Cho Chou Kuo; Julius Schachter; Walter E Stamm; Guangming Zhong
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

7.  Shear Stress Enhances Chemokine Secretion from Chlamydia pneumoniae-infected Monocytes.

Authors:  Shankar J Evani; Shatha F Dallo; Ashlesh K Murthy; Anand K Ramasubramanian
Journal:  Cell Mol Bioeng       Date:  2013-09-01       Impact factor: 2.321

8.  Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model.

Authors:  Andrei Kutlin; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

9.  Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?

Authors:  M Di Pietro; G Schiavoni; V Sessa; F Pallotta; G Costanzo; R Sessa
Journal:  Osteoporos Int       Date:  2012-11-16       Impact factor: 4.507

10.  Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.

Authors:  Yuri V Bobryshev; Murray C Killingsworth; Dihn Tran; Reginald Lord
Journal:  Virchows Arch       Date:  2008-06-06       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.